Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-05-22 @ 3:05 AM
Study NCT ID:
NCT03205267
Status:
UNKNOWN
Last Update Posted:
2017-07-02
First Post:
2017-05-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients
Sponsor:
University of Bonn
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myelogenous Leukaemia | View |
Keywords: